Stock Analysis
Cardinal Health, Inc. (CAH) Stock Analysis
Cardinal Health, Inc. (CAH) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Cardinal Health, Inc. (CAH) currently has an AIQ Score of 53/100, indicating a neutral setup. Momentum is the strongest factor at 73/100. Quality is the weakest current factor at 32/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
CAH at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $250.48 |
| AIQ Score | 53/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Strong Buy |
| Market Cap | $56.06B |
| P/E Ratio (TTM) | 32.92 |
| Forward P/E | — |
| EPS (quarter ended 2026-06-30) | $1.71 |
| Revenue (quarter ended 2026-06-30) | $63.86B |
| Dividend Yield (TTM) | 0.86% |
| Beta | 0.52 |
| Volume | 1.95M |
| 52-week range | $161.64-$259.21 |
| RSI 14 | 64.74 |
| 50-Day SMA | $237.33 |
| 200-Day SMA | $221.97 |
| Analyst Price Target | $275.67 |
| Next Earnings | Nov 5, 2026 |
CAHCardinal Health, Inc.
Healthcare / Medical - Distribution
Low Priority
In Line With Peers
Latest quote
- Momentum73
- Value56
- Quality32
- Risk resilience55
- Sentiment—
CAH Stock Analysis Summary
Cardinal Health, Inc. (CAH) currently has an AIQ Score of 53/100, indicating a neutral setup. Momentum is the strongest factor at 73/100. Quality is the weakest current factor at 32/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, CAH has AIQ Score of 53/100 with Momentum base of 73/100 and fading Quality at 32/100. Wait for component alignment before adding exposure.
Momentum (73/100) leads while Quality (32/100) lags. This cross-factor spread creates entry timing uncertainty.
Healthcare · -0.24% stock move · CAH classified in Medical - Distribution.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is CAH Bullish or Bearish Right Now?
CAH currently has a neutral overall setup. Momentum is the strongest factor at 73/100, while Quality is weakest at 32/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Momentum is constructive at 73/100.
- - Price is +5.80% above its 50-day SMA.
- - Analyst target implies +10.06% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (32 vs 6).
- - No strong bearish evidence is available in the current snapshot.
Current Consensus
CAH's Technical Analysis Consensus is currently Strong Buy, with 32 buy, 7 neutral, and 6 sell votes. CAH's 14-day RSI is 64.74, which places the stock in a constructive momentum range. CAH's beta is 0.52, indicating lower market sensitivity than the broad market.
What Changed in CAH?
The largest recent change in CAH is Momentum moving down by 13.0 points over the available 7-day comparison window. Momentum remains the strongest visible factor.
What Would Change the CAH Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
CAH Decision Framework
Public evidence layers, setup checks, and risk context for Cardinal Health, Inc..
Cardinal Health, Inc. (CAH) Stock Analysis
Cardinal Health, Inc. has an AIQ Score of 53/100 in a Neutral regime. Momentum is strongest at 73/100. Beta is 0.5, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | CAH is in a Neutral AIQ regime with score 53/100. |
| Signal Conflict | The primary conflict is that momentum leads at 73/100 while quality lags at 32/100. |
| Factor Evidence | Momentum 73/100 · Value 56/100 · Quality 32/100 · Risk 55/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Momentum is the strongest factor at 73/100.
Momentum is 73/100 and RSI (14) is 64.7.
CAH is in a Neutral regime at 53/100.
Risk factor is 55/100 with beta 0.5 and annual volatility 29.94%.
Current conflict: momentum leads at 73/100 while quality lags at 32/100.
CAH Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
CAH Fundamentals
CAH valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
CAH Technical Analysis
CAH technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
CAH Stock Catalysts
Track CAH earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
CAH Dividend Analysis
CAH dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
CAH Financial Data
CAH revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
CAH Risk Analysis
CAH volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
CAH Stock News
CAH stock news, market tone, recent headlines, and catalyst context.
CAH vs Healthcare Services / Managed Care Peers
Current peer cohort: CAH · CI · CLOV · CNC · COR. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| CAH Current stock | 53/100 | 56/100 | 73/100 | 55/100 | 1.43 | 29.94% | Current |
| CI Cigna | 59/100 | 72/100 | 73/100 | 48/100 | 0.04 | 32.60% | CAH vs CI |
| CLOV Clover Health | 43/100 | 42/100 | 56/100 | 33/100 | 0.61 | 62.09% | CAH vs CLOV |
| CNC Centene | 50/100 | 53/100 | 69/100 | 56/100 | 1.48 | 45.65% | CAH vs CNC |
| COR Cencora | 56/100 | 61/100 | 64/100 | 60/100 | 0.01 | 31.31% | CAH vs COR |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 29, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts3 recent quarterly periods are available for review.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Jun 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching CAH
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for CAH
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
CAH Stock FAQ
What is CAH stock price today?
Cardinal Health, Inc.'s current stock price is $250.48. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is CAH bullish or bearish right now?
CAH's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is CAH's market cap?
CAH's market cap is $56.06B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is CAH's current P/E ratio?
CAH's current P/E ratio is 32.92 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is CAH's RSI?
CAH's 14-day RSI is 64.74 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is CAH above its 50-day and 200-day moving averages?
CAH is 5.80% from its 50-day SMA and 13.12% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is CAH's next earnings date?
CAH's next earnings date is currently listed as Nov 5, 2026. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does CAH pay a dividend?
CAH's dividend yield is 0.86% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.